Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.86 million shares were traded. HCSG stock price reached its highest trading level at $16.79 during the session, while it also had its lowest trading level at $16.04.
Ratios:
To gain a deeper understanding of HCSG’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.04. For the most recent quarter (mrq), Quick Ratio is recorded 2.41 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 24, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $15.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 28 ’25 when SHEA JOHN CHRISTOPHER sold 21,368 shares for $13.25 per share. The transaction valued at 283,126 led to the insider holds 32,976 shares of the business.
John Shea bought 21,368 shares of HCSG for $283,126 on Jul 28 ’25. On Feb 26 ’25, another insider, Brophy Andrew M, who serves as the SVP & Chief Accounting Officer of the company, sold 1,744 shares for $10.45 each. As a result, the insider received 18,225 and left with 12,424 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCSG now has a Market Capitalization of 1184672256 and an Enterprise Value of 1065531200. As of this moment, Healthcare’s Price-to-Earnings (P/E) ratio for their current fiscal year is 115.62, and their Forward P/E ratio for the next fiscal year is 17.51. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67 while its Price-to-Book (P/B) ratio in mrq is 2.48. Its current Enterprise Value per Revenue stands at 0.601 whereas that against EBITDA is 70.267.
Stock Price History:
The Beta on a monthly basis for HCSG is 0.69, which has changed by 0.4646374 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, HCSG has reached a high of $16.59, while it has fallen to a 52-week low of $9.12. The 50-Day Moving Average of the stock is 9.16%, while the 200-Day Moving Average is calculated to be 26.34%.
Shares Statistics:
It appears that HCSG traded 830.09K shares on average per day over the past three months and 757650 shares per day over the past ten days. A total of 72.41M shares are outstanding, with a floating share count of 71.58M. Insiders hold about 1.16% of the company’s shares, while institutions hold 103.61% stake in the company. Shares short for HCSG as of 1757894400 were 1746174 with a Short Ratio of 2.10, compared to 1755216000 on 2005299. Therefore, it implies a Short% of Shares Outstanding of 1746174 and a Short% of Float of 3.47.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 3.83. . The current Payout Ratio is 0.00% for HCSG, which recently paid a dividend on 2022-11-17 with an ex-dividend date of 2022-11-17. Stock splits for the company last occurred on 2010-11-15 when the company split stock in a 3:2 ratio.
Earnings Estimates
. The current assessment of Healthcare Services Group, Inc (HCSG) involves the perspectives of 4.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.22, with high estimates of $0.22 and low estimates of $0.22.
Analysts are recommending an EPS of between $0.88 and $0.86 for the fiscal current year, implying an average EPS of $0.87. EPS for the following year is $0.93, with 4.0 analysts recommending between $0.99 and $0.89.
Revenue Estimates
In . The current quarter, 4 analysts expect revenue to total $460.36M. It ranges from a high estimate of $461.1M to a low estimate of $459.63M. As of . The current estimate, Healthcare Services Group, Inc’s year-ago sales were $428.15MFor the next quarter, 4 analysts are estimating revenue of $465.2M. There is a high estimate of $466.4M for the next quarter, whereas the lowest estimate is $463.95M.
A total of 4 analysts have provided revenue estimates for HCSG’s current fiscal year. The highest revenue estimate was $1.83B, while the lowest revenue estimate was $1.83B, resulting in an average revenue estimate of $1.83B. In the same quarter a year ago, actual revenue was $1.72BBased on 4 analysts’ estimates, the company’s revenue will be $1.92B in the next fiscal year. The high estimate is $1.94B and the low estimate is $1.9B.
